Connect with others who understand.

sign up log in
About myHIVteam

New Drug of Last Resort Tackles Resistant HIV

Posted on December 20, 2018


By Serena Gordon, HealthDay Reporter

THURSDAY, Aug. 16, 2018 (HealthDay News) -- HIV, the virus that causes AIDS, is typically a manageable infection, but medications that keep the virus at bay don't work for everyone. Now, researchers have developed a new medication to help them.

The U.S. Food and Drug Administration approved the drug -- ibalizumab (Trogarzo) -- in March. Phase 3 trial results were published in the Aug. 16 issue of the New England Journal of Medicine.


"For those who have exhausted their current [drug] regimen, we now have another hope," the study's senior author, Dr. Stanley Lewis, said of the new drug. He's chief medical officer for TaiMed Biologics, maker of the drug and sponsor of the trial.

"HIV is probably the most dynamic pathogen in medicine. It's been a challenge to stay one step ahead of it," Lewis said.

The new drug is called a monoclonal antibody. It works by binding to receptors on CD4 cells. (CD4 is a type of immune system cell also known as T cells.) This blocks the virus from entering CD4 cells.

In an editorial accompanying the study, the FDA's Dr. Virginia Sheikh and colleagues wrote that "patients with multidrug-resistant HIV infection are at risk for illness and death because of their limited remaining treatment options."

Because of these serious risks, the FDA allowed a streamlined clinical trial of ibalizumab.

The study included 40 adults with multidrug-resistant HIV-1 infection. More than half had been treated unsuccessfully with a median of 10 drugs.


The researchers observed for a week how well the study participants' current treatment regimens were working. Then they added ibalizumab. Eighty-three percent saw a reduction in the amount of HIV in their body (called "viral load"), the findings showed.

After the first week of ibalizumab, participants were given the drug once every two weeks for 25 weeks. Their drug regimens also were optimized to ensure they were getting at least one drug that the virus was sensitive to, according to Lewis.

At week 25, the drug successfully reduced patients' overall viral load. In fact, almost half had viral loads that were considered undetectable.

However, the drug did have side effects -- some serious.

More than 5 percent of patients reported having diarrhea, dizziness, nausea
and rash, Sheikh said.

One patient had "immune reconstitution inflammatory syndrome," or IRIS, which Lewis described as an immune system overreaction. HIV hampers the body's ability to respond to infections. With IRIS, that immune system response is out of balance and causes inflammation, he said. This side effect is temporary.

Four patients in the trial died; their deaths were believed to be related to the underlying HIV infection.

Sheikh said the FDA will continue to monitor side effects, and update safety information on drug labels as needed.

Both Lewis and Sheikh said it's possible that HIV will eventually develop resistance to ibalizumab, too.

Lewis said he doesn't know what the drug costs, but said it was expected to be in line with other monoclonal antibodies. He added that it would likely be cheaper than some other drugs in that class.


SOURCES: Stanley Lewis, M.D., chief medical officer, TaiMed Biologics, Irvine, Calif.; Virginia Sheikh, M.D., medical officer, Center for Drug Evaluation and Research, U.S. Food and Drug Administration; Aug. 16, 2018, New England Journal of Medicine
Copyright © 2018 All rights reserved.

Here are some questions and conversations from myHIVteam:

New Treatment?

How do any of you manage to stay on medication and take them on time?

How is exercising with HIV or while taking ART?

Has antiretroviral therapy helped you successfully reduce your viral load?
Share in the comments below or directly on myHIVteam.

A myHIVteam Member said:

This Article Proves That AIDS is Still an On Going PROBLEM. Even with All these New fandangled Drugs, this Virus is STILL Deadly. I have changed ART… read more

posted over 1 year ago

hug (1)

Recent articles

Myhivteam heromain carousel
Article written by Nyaka Mwanza When a person has drug-resistant HIV, one or more HIV medications...

HIV-1 Drug Resistance: What You Need to Know

Article written by Nyaka Mwanza When a person has drug-resistant HIV, one or more HIV medications...
2020 05 26 myhivteam heromain carousel
Article written by Nyaka Mwanza What Is Lipohypertrophy?Lipodystrophy syndrome is an abnormal...

Hard Belly and HIV

Article written by Nyaka Mwanza What Is Lipohypertrophy?Lipodystrophy syndrome is an abnormal...
11 app icon ios
Our Provider Directory is a source of provider information submitted by members and providers. To...

How do I search for a provider?

Our Provider Directory is a source of provider information submitted by members and providers. To...
11 app icon ios
Notifications are alerts to let you know when another member has taken some kind of action...

What are notifications?

Notifications are alerts to let you know when another member has taken some kind of action...
11 app icon ios
To add a photo to a new post, comment, or question, select the camera icon in the lower right...

How do I add a photo to an update?

To add a photo to a new post, comment, or question, select the camera icon in the lower right...
Ready to stop judging yourself
"I was tired of listening to my harshest critic, the little voice in my head, so I became more...

Ready to Stop Judging Yourself?

"I was tired of listening to my harshest critic, the little voice in my head, so I became more...
Setting intentions for 2020 with hiv
Eat healthier. Exercise more. Learn a new skill. Pay off a credit card. Many of us have made...

Setting Intentions for 2020 With HIV

Eat healthier. Exercise more. Learn a new skill. Pay off a credit card. Many of us have made...
Coronavirus
Article written by Kelly Crumrin According to Harvard Medical School, some people living with HIV...

Canceling Is Kindness: Keeping Safe From COVID-19 With HIV

Article written by Kelly Crumrin According to Harvard Medical School, some people living with HIV...
Dental problems and hiv
If you’ve experienced more dental health problems since contracting HIV, you’re not alone. HIV...

Dental Problems and HIV

If you’ve experienced more dental health problems since contracting HIV, you’re not alone. HIV...
11 app icon ios
If you would like to block a member from posting on your profile or on your content, you can...

How do I block/unblock another member?

If you would like to block a member from posting on your profile or on your content, you can...
myHIVteam My HIV Team

Two Ways to Get Started with myHIVteam

Become a Member

Connect with others who are living with HIV. Get members only access to emotional support, advice, treatment insights, and more.

sign up

Become a Subscriber

Get the latest articles about HIV sent to your inbox.

Not now, thanks

Privacy policy
myHIVteam My HIV Team

Thank you for signing up.

close